■ Abstract Currently, more than 10 million DNA sequence variations have been uncovered in the human genome. The most detailed variation discovery efforts have focused on candidate genes involved in cardiovascular disease or in susceptibilities associated with exposure to environmental agents. Here we provide an overview of natural genetic variation from the literature and in 510 human candidate genes resequenced for variation discovery. The average human gene contains 126 biallelic polymorphisms, 46 of which are common (≥5% minor allele frequency) and 5 of which are found in coding regions. Using this complete picture of genetic diversity, we explore conservation, signatures of selection, and historical recombination to mine information useful for candidate gene association studies. In general, we find that the patterns of human gene variation suggest that no one approach will be appropriate for genetic association studies across all genes. Therefore, many different approaches may be required to identify the elusive genotypes associated with common human phenotypes.
INTRODUCTION
Since the completion of the sequencing of the human genome (46, 108) , there have been great strides in cataloguing and describing human gene variation (e.g., 83 ). The most common genetic variation in the human genome is the single nucleotide polymorphism (SNP). Currently, there are more than 10 million SNPs recorded in dbSNP (build 123), the public repository for DNA variations (see Electronic Databases). With a complete catalogue of common SNPs nearly in sight, investigators are now developing methods to apply SNPs to genetic association studies with the hopes of identifying DNA variants that contribute to an increased susceptibility to human diseases. With this in mind, we use this review to not only describe the patterns of human gene variation, but also to practically demonstrate how this variation may be applied to the next generation of well-designed genetic association studies.
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and individual genotypes, are routinely deposited in GenBank and dbSNP, the public repository for DNA variations (91, 92, 113) . All DNA variations and corresponding data are also available for viewing and/or download on our Web sites (see Electronic Databases), and the list of genes analyzed here can be requested from the authors.
DNA sequence variations annotated by these two projects consist of both SNPs and insertion/deletion polymorphisms (3), collectively referred to as SNPs here. The occurrence of SNPs across the human genome is common, with one approximately every 180 bp, based on resequencing 137 individuals. The estimate from these data agrees with estimates derived from population genetics theory (55) and from empirical estimates based on other resequencing surveys (43, 96) . Although the occurrence of SNPs across the genome is frequent, we and other investigators find that most SNPs are rare (64% of all SNPs), with a minor allele frequency (MAF) of <5%. Also, fewer SNPs are within coding regions of the gene [coding SNPs (cSNPs) 4%] compared with noncoding regions of the gene (96%), as previously observed (42, 58) . The average gene in the combined SeattleSNPs PGA and EGP data sets (such as VCAM1) (Figure 1 ) has 126 SNPs, 46 of which are common (MAF ≥ 5%) and 5 of which are cSNPs. These observations have major implications for performing candidate gene association studies using either direct or indirect approaches, both of which we discuss further below.
ASSOCIATION STUDIES AND SINGLE NUCLEOTIDE POLYMORPHISMS
Association studies have become the focus of most study designs for identifying loci that are involved in complex, common human disease (e.g., heart disease, stroke, diabetes, and cancer). Prior to the completion of the Human Genome Project and the emergence of dense genetic maps, investigators used linkage studies and positional cloning to identify DNA mutations that caused rare disorders such as cystic fibrosis (52, 81 ) and Huntington's disease (40, 104) . Despite the success of identifying genes segregating in classic Mendelian fashion as recessive or dominant disorders (37) , investigators have been less successful in identifying loci that contribute to complex, common diseases. A landmark paper in 1996 by Risch & Merikangas (82) suggested that association study designs could be more powerful compared with linkage study designs in identifying the elusive susceptibility loci that geneticists seek. Furthermore, it was suggested that common DNA variation, as opposed to rare mutations, could be responsible for a proportion of common human diseases [i.e., the common variant/common disease (CV/CD) hypothesis ] (14, 22, 56) . Even though these suggestions and their potential for success in identifying genetic loci involved in common human diseases remain controversial (112) , resources for association studies, such as dense genetic maps of SNPs across the human genome, are enabling investigators to more rapidly identify disease-causing loci that could potentially have a major impact on public health (21) .
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CRAWFORD AKEY NICKERSON
THE "DIRECT" APPROACH
As investigators begin to mine the resources available for association designs, two approaches have emerged for studying candidate genes: direct and indirect (22) . In a direct candidate gene association study, the putative causative SNP is genotyped directly. The challenge of this approach is predicting or determining a priori which SNPs are likely to be causative or predict the phenotype of interest. Oftentimes, a SNP is suspected to be causative if it is a nonsynonymous SNP (nsSNP); that is, if the cSNP changes the amino acid in the protein of the gene of interest (reviewed in 5). For example, in a simple yet elegant experiment, Cohen et al. (19) hypothesized that genetic variants in three candidate genes are responsible for very low levels of high-density lipoprotein cholesterol (HDL-C), and that these variants would be found more often in individuals with low HDL-C compared with individuals with high HDL-C. Cohen et al. (19) resequenced the coding regions and splice sites of three candidate genes within individuals with extremely low and high levels of HDL-C and identified several nsSNPs over-represented among individuals with low HDL-C compared with high HDL-C. In contrast to the positive finding of rare SNPs contributing to the phenotype, no association was identified with common SNPs (MAF > 10%) and HDL-C in one population examined as part of the Dallas Heart Study (19) , further affirming the utility and success of the "direct" candidate gene approach for this phenotype.
Although the direct approach using nsSNPs has proven successful, it is not without serious challenges. The first major challenge is the fact that cSNPs in general are fewer in number within genes compared with noncoding SNPs (noncSNPs) (42, 58) . Also, cSNPs are rarer than noncSNPs, resulting in a lower average MAF among cSNPs compared with noncSNPs (38, 107) . This challenge is particularly relevant to SNP discovery strategies. Currently, the goal of many large-scale SNP discovery projects is to catalogue common human DNA variation (23) . Both the SeattleSNPs PGA and EGP projects resequence a sample size necessary to capture common variation (MAF > 5%) at a detection rate of 95% (55) in at least two populations: African Americans and European Americans. SNPs with a MAF < 5% would require twice the sample size (96 chromosomes) for a similar detection rate (55) . Alternatively, rarer cSNPs could be more readily identified by resequencing individuals in the extreme upper and lower percentile of a specific phenotype, as did Cohen et al. (19) . For both approaches, to obtain the complete catalogue of SNPs, including both coding and noncoding, will require more effort and resources.
A second challenge is that not all cSNPs are deleterious. Only approximately half of the cSNPs are nsSNPs in the general population (6, 7, 43, 84, 87, 96) , with only a fraction predicted to be deleterious to protein function. Recent strides, however, have been made in the development of tools that predict in silico the effect a nsSNP has on gene function. These tools (e.g., SIFT and PolyPhen) use structural criteria and sequence homology to predict nsSNP function (15, 18, 67, 78, 102) .
In our SeattleSNPs PGA and EGP data sets, 2778 (4.3%; 1 every 4 kb) of the SNPs discovered are classified as cSNPs (synonymous and nonsynonymous), of which 1396 (2.2% of all SNPs) are classified as nonsynonymous. Similar to another large-scale resequencing survey (96) , the average gene across both data sets contains four cSNPs, half of which are nsSNPs. Of all nsSNPs in the SeattleSNPs PGA and EGP, 186 are classified as "intolerant" by SIFT and "probably damaging" or "possibly damaging" by PolyPhen. Many of these potentially deleterious cSNPs do not seem to be randomly distributed across the 510-gene data set; that is, many of these cSNPs are clustered in a few genes, such as CYP4F2 (three potentially deleterious cSNPs) in the SeattleSNPs PGA data set and CYP2C9 (four potentially deleterious cSNPs) in the EGP data set.
A list of the potentially deleterious cSNPs was recently reviewed for the EGP data set (58) . To summarize those data, 57 cSNPs out of 541 nsSNPs in the EGP were predicted to be intolerant by both SIFT and PolyPhen (58) . For the SeattleSNPs PGA data set, 69 nonsynonymous cSNPs are predicted by both PolyPhen and SIFT to be deleterious to protein function ( In addition to these 37 potentially detrimental cSNPs, of the 69 SeattleSNPs PGA nonsynomous cSNPs, 8 are associated with a known phenotype as reported in the Human Gene Mutation Database. For example, all three of the ABO cSNPs listed in Table 1 (P74S, R176G, and F216I) were previously identified and correspond to ABO blood group variation (69, 115) . Also, KEL R281W was previously reported as a kell blood group variant (57), IL4R C431R is associated with IgE levels (41), MC1R R151C and R160W are associated with red hair color and vulnerability to UV-induced skin damage (34, 95) , and TNFRSF1B M196R is associated with hyperandrogenism and polycystic ovary syndrome (72) . Considering that 8 of the 69 potentially deleterious cSNPs are associated with a phenotype, these data suggest that the remaining 61 potentially deleterious cSNPs listed in Table 1 are good candidates for disease association and functional studies.
Besides the potentially deleterious nsSNPs, such as the ones described above, there are several other SNPs that should be considered candidates for direct candidate gene association studies. These include SNPs that introduce stop codons and cause premature truncation of the protein, SNPs that alter splice sites, and diallelic insertion/deletion polymorphisms that cause frame shifts. The SeattleSNPs PGA and EGP projects have identified a total of 16 SNPs that introduce a premature stop codon, 15 SNPs that alter splice sites, and 23 insertion/deletion polymorphisms that cause a frame shift with a frequency of one per 0.22 megabases resequenced, collectively ( Table 2 ). Most of these SNPs are found only once or twice in the samples resequenced, suggesting that these SNPs may represent mutations (defined as having a MAF < 1% in the general population). A few of these SNPs are common, such as the nonsense SNP in IL16 (Table 2) , which has a MAF of 0.15 in the African-American sample and 0.22 in the European-American sample. The final class of SNPs that could be considered for direct candidate gene association studies is the regulatory SNP group. These SNPs could include any SNP that affects regulation of gene expression without changing an amino acid of the protein. Typically, SNPs that occur in the promoter or untranslated regions (UTR) of the gene are likely candidates for SNPs that affect gene expression because it is assumed that disruption of the promoter could affect transcription factor binding or disruption of the UTR sequence could affect mRNA stability, translation, or transportation to other components of the cell (e.g., 44). In the SeattleSNPs PGA and EGP data sets, we have identified 566 and 2060 SNPs in the 5 and 3 UTRs, respectively, that could be considered candidates for being regulatory SNPs.
Although the UTRs of genes are obvious candidates for regulatory SNPs, this class of SNPs can also be extended to include exonic or intronic SNPs that were once thought to be neutral polymorphisms. Shen et al. (90) demonstrated that synonymous cSNPs can alter mRNA structure, which may affect many downstream processes such as splicing, processing, and even translation. In another example, a synonymous SNP in exon 14 of the APC gene causes exon skipping and is associated with Familial Adenomatous Polyposis (64). The "silent" cSNP in APC is one of a growing list of synonymous SNPs that alter splicing (reviewed in 11). Finally, an intronic SNP in the programmed cell death 1 (PDCD1) gene alters the binding site of the runt-related transcription factor 1 (RUNX1) and is associated with systemic lupus erythematosus (77) .
Seemingly, any SNP could be a regulatory SNP. The challenge, of course, is to identify the regulatory SNP among the neutral SNPs so that the regulatory SNP can be genotyped in a candidate gene association study. Currently, most computational tools concentrate on predicting whether or not a nsSNP is deleterious; however, a few tools exist that predict regulatory SNPs. Current tools have taken several approaches to mining vast amounts of experimental and sequence data available in the public domain. For example, the database TRANSFAC contains curated eukaryotic transcription factor and DNA binding specificities from the literature (114) , and the Eukaryotic Promoter Database (EPD) contains eukaryotic polymerase II promoters experimentally derived from transcriptional start sites (86) . Many algorithms that predict transcriptional binding sites rely on the observation that transcriptional control is generally conserved across species. These algorithms [ConSite (85) , CORG (30), PromoLign (117), rVISTA (60) , and TraFaC (48)] use humanmouse orthologous sequence alignments as well as other cross-species alignments to identify putative transcription factor binding sites and other cis-regulatory elements. Other tools, such as the web-based PupaSNP (24) and ESEfinder (12) , include the prediction of exonic splicing enhancers as potential functional SNPs.
Approximately 50% of the human genomic sequence is repetitive, and only 5% is predicted to be coding (46) . Nearly half of the human genome has no known function. Recognizing the need to further annotate the list of functional SNPs, the National Human Genome Research Institute at the National Institutes of Health recently launched a collaborative project entitled the "Encyclopedia of DNA Elements" or ENCODE (21) . The goal of ENCODE is to identify all the functional elements of the human genome. To do this, diverse yet complementary computational and experimental approaches will be developed in a high-throughput manner. Already, computational comparisons of genome sequences across species, such as the mouse/human comparison where 40% of the human sequence aligns to the mouse sequence (66) , have identified interesting conserved noncoding regions that are candidates for being regulatory regions in the human genome (reviewed in 63, 71, 94) . Ideally, ENCODE would also include high-throughput experimental approaches that would confirm functional elements identified through computational approaches. Traditionally, these experimental approaches include DNA footprinting, gel shift assays, deletion constructs, DNASE I hypersensitivity studies, and gene trapping (including promoter and enhancer trapping) (reviewed in 31, 71). All of these approaches are time intensive at the single gene level and will require further attention to make them amenable for high-throughput identification of functional DNA elements in the human genome.
ASSOCIATION STUDIES AND SINGLE NUCLEOTIDE POLYMORPHISMS: THE "INDIRECT" APPROACH
The "indirect" approach to genetic association studies differs from the direct approach described above in that the causal SNP is not assayed directly. The indirect approach is much like a linkage study in that the study design assays many presumably neutral markers and makes no assumption on the location of the causative gene or locus. Linkage studies are family based and rely on recombination events within the pedigree to narrow the genomic region that contains the causative gene segregating within the families being studied. The indirect genetic association study is most often a case-control study drawn from the general population. Although this review focuses on indirect candidate gene association studies, this approach can be used to interrogate whole genomes and genomic regions (reviewed in 8). Like a linkage study, the indirect approach also relies on recombination to narrow the genomic region related to the phenotype. The difference is that an association study, because it is drawn from a population, uses a measure of allelic association or site correlation, known as linkage disequilibrium (LD), to detect historical recombination. The assumption is that the assayed or genotyped SNPs will be in LD or associated with the causative SNP; thus, the assayed SNP would be overrepresented among cases compared with controls because it is highly correlated with the disease-causing SNP.
The success of an indirect association study, whether at the whole genome or candidate gene level, hinges on several assumptions and parameters. The first assumption is that the disease or phenotype in question has a strong (or measurable) genetic component. The average gene in our SeattleSNPs PGA and EGP data set contains approximately 126 SNPs, of which most are neutral polymorphisms. Therefore, the presence of genetic variation alone (or even extremely high or low levels of variation) does not provide evidence that a phenotype associated with the candidate gene has a strong genetic component. The evidence for a strong genetic component is usually derived from twin studies and family studies. Although these studies are popular and important sources of evidence, it is important to realize that heritability estimates depend on the population being studied as well as the time and location of the study (reviewed in 65, 109) . Also, it is often incorrectly assumed that strong heritability indicates that there is a single major gene underlying the disease or trait. Finally, most studies estimating heritability are biased in that they overestimate the effects of major genes. These limitations on our ability to estimate the strength of the genetic component could have a significant impact on our ability to design the optimal study to detect disease-susceptibility loci for a given phenotype.
A second assumption commonly made at the onset of study design is that, for a given common human disease, only a few common variants are associated with it (14, 22, 56) . A few examples exist in which "common" variants are consistently associated with a common disease phenotype [e.g., CARD15 and Crohn's disease (45) ; APOE and Alzheimer's disease (33) ]. However, some investigators argue that not all common human disease can be attributed to a few common variants, and that it is more likely that several rare variants at several sites (genetic and allelic heterogeneity) could result in the phenotypes being studied (74, 75, 112) . To further complicate matters, the notion of "common" is arbitrary, with some investigators defining this as an allele with >20% MAF and others defining this as an allele with >1% MAF. This seemingly arbitrary decision to limit the set of potential SNPs (usually on the basis of genotyping costs and effort) to those with a certain allele frequency may have serious consequences on the power of the study to detect a difference between cases and controls. Recent work has established that the most efficient and powerful studies that can detect diseasesusceptibility alleles are those in which the allele frequency differences between the genotyped SNP and the disease-causing or -susceptibility SNP are small (reviewed in 119). If the difference in allele frequencies between the genotyped SNP and the disease-causing SNP is large, especially in the case where the diseasecausing SNP is rarer than the genotyped SNP (51), it is likely that only studies searching for genetic determinants of large phenotypic effects will be successful (119) .
A third assumption made in designing indirect association studies is that there will be useful levels of LD within the genomic region of the population studied and that these levels of LD can help determine which and how many markers should be genotyped in the study. In general, regions of the genome with large stretches of LD are desirable in an association study because fewer markers have to be genotyped; however, these regions become less desirable when the investigator tries to tease the disease-causing SNPs from the other SNPs in LD with it (76, 80) . Despite the double-edged sword effect of LD, there is great interest in describing LD properties across the genome and developing strategies to choose SNPs for genotyping based on these patterns.
Using the resequencing data generated across the 510 SeattleSNPs PGA and EGP data sets, we can describe LD across candidate genes using the measure r 2 (Figure 2 ). Pair-wise LD can also be measured using D , which is useful in describing historical recombination in a sample. The r 2 measure is preferred in this context because there is an inverse relationship between this measure and the power to detect an association (reviewed in 76, 110) . As demonstrated in Figure 2a ,b,c, the strength of LD can vary dramatically across candidate genes. For example, for two similar-sized genes, TGFB3 (∼24 kb) and IL1R2 (∼23 kb), the strength and extent of LD is different even within the same European-American sample ( Figure  1a,c) . The strength and extent of LD is also different within the same gene but across population samples (Figure 2a,b) . The difference in LD patterns between populations can be an asset in specific situations where the phenotype is the same between the two populations, but the levels of LD are different so that an association can be detected with a minimal number of markers, but the causative SNP could also be identified (61, 118) . This is a strategy that essentially circumvents the doubleedged sword effect often observed with studying genotype-phenotype correlations in only one population.
The strength and extent of LD is influenced by several factors. It is well documented that LD decays with increasing physical distance (1, 3) . Also, Africandescent populations typically have less LD or shorter-ranged LD compared with European-descent populations due to differences in population history (35, 38, 53, 79, 84, 87, 93, 106) . This is also evident in our SeattleSNPs PGA candidate gene set. Other population structures, such as isolated populations (54) and recently admixed populations (13) , are predicted to have long stretches of LD compared with other populations, although there is evidence that contradicts these predictions (32, 59) .
Another factor that influences the structure of LD is natural selection. Evidence for natural selection can be assessed in sequence data using several statistics that summarize the allele frequency distribution within samples for the region of interest. One such popular test statistic is Tajima's D, which tests departure from neutrality using two measures of nucleotide diversity (103) . Tajima 's D, however, can be explained by population demography or history; therefore, a more careful examination of these values must be performed before conclusions about departures from neutrality can be made for these genes (2).
Finally, another major factor influencing the structure of LD is recombination. The relationship between the strength of LD and the amount of recombination is evident at both the candidate gene level (e.g., 17) and the genome-wide level. For example, in a detailed study of chromosome 22 in European-American samples (ascertained from available Center d'Etude du Polymorphisme Humain samples), Dawson et al. (29) demonstrated that LD tends to be strongest in areas of little or no recombination, in addition to decaying as the physical distance increases. Also, Clark et al. (16) examined 4833 SNPs typed in 538 clusters across the human genome and identified a negative correlation between the LD metric r 2 and the recombination rate ρ.
Collectively, all of these factors (population history, natural selection, and recombination) make it difficult to predict a priori which regions of the human genome will have levels of LD acceptable for genetic association studies. Despite this limitation, several groups are optimistic that the human genome can be described based on patterns of LD. Both candidate genes (101) and regions in the human genome (27) have been described as having regions of high LD (termed "blocks") separated or punctuated by regions of low LD, presumably caused by hot spots of recombination. The "haplotype blocks" contain a few common haplotypes accounting for most of the chromosomes assayed (27) . Gabriel et al. (36) formalized the definition of haplotype blocks and demonstrated that haplotype blocks existed across the human genome in several different populations, although African-descent samples had a greater number of short blocks compared with non-African-descent samples.
Studies on haplotype block structure (36, 70) were immediately influential because they provided the framework from which to choose SNPs for genotyping in a genetic association study (49) . These data also provided impetus for the International HapMap Project, an international collaborative effort designed to describe LD across the human genome in several populations and the tagSNPs needed to capture genetic diversity that can be applied in future genetic association studies (105) . However, since the publication of these findings, several investigators have demonstrated that, even though hot spots of recombination may be a common feature of the human genome (25, 62) , haplotype blocks can exist without their presence (73, 111) . Furthermore, studies show that the number and size of haplotype blocks depend on marker density (50, 98) , the MAF cutoff imposed on the data set (88, 100) , and block definition (89) . These recent findings will no doubt increase the usefulness of the International HapMap Project as researchers investigate new avenues to describe LD and genetic diversity across the human genome and ways to apply this knowledge in well-designed genetic association studies.
As the genetics community waits for the whole-genome association study resources to be developed by the HapMap, many investigators are continuing work on candidate genes in association studies. Several useful algorithms have been developed to choose SNPs for genotyping that can be applied to candidate genes. Most algorithms available today are based on choosing SNPs that represent common haplotypes (usually defined as having a frequency of >5% in the sample) or maximize haplotype diversity within blocks (49, 99, 116) . The disadvantage of this approach is that these algorithms require haplotypes. To date, most haplotype data represent inferred haplotypes, not molecularly determined haplotypes. It is clear that genomic regions with high haplotype diversity are difficult to phase correctly (68) and that, no matter the algorithm used, a fraction of the inferred haplotypes is incorrect (97) . Also, we recently showed in the SeattleSNPs PGA data set that the number of inferred haplotypes per gene varies substantially across genes and between populations (26) (Figure 4 ). For example, the average number of inferred haplotypes per gene is 34 for the SeattleSNPs PGA and 38 for the EGP (Figure 4a ). In contrast, the range for the number of haplotypes per gene is quite broad: 7 to 94 in the SeattleSNPs PGA and 2 to 175 in the EGP (Figure 4a) . Also, as shown previously (4, 26), the average number of haplotypes per gene, as well as the range of haplotypes per gene, is greater in the African-American sample compared with the European-American sample: 25 versus 15 (Figure 4b ). In general, the larger genes have the most haplotypes because there is a positive correlation between the increasing number of SNPs and the increasing number of haplotypes. However, there are always exceptions, such as CCND2, a gene with 100 inferred haplotypes that is only 33.5 kb in size and contains 48 SNPs with MAF ≥ 5%. We found that haplotype diversity was high in a few genes such that no common haplotypes (>5% frequency) were inferred for that sample (26) . These data demonstrate that a proportion of genes have high haplotype diversity, perhaps making them less amenable to haplotype tagging approaches.
One tagSNP selection algorithm that does not require the inference of haplotypes across the entire gene is LDSelect, an algorithm that groups correlated SNPs from genotype data using linkage disequilibrium (10) . At an empirically determined r 2 threshold of 0.64 and a minor allele frequency ≥5%, we identified 3709 and 1807 tagSNPs for genotyping in the African-American and EuropeanAmerican samples, respectively, across 180 genes in the SeattleSNPs PGA data set. The average number of tagSNPs per gene is 21 for the African-American sample and 10 for the European-American sample. Even though twice as many tagSNPs must be genotyped on average for the African-American sample compared with the European-American sample at this particular r 2 threshold, the number of SNPs required for genotyping represents a great savings because the tagSNPs only account for 36% of the total number of SNPs with MAF ≥ 5% in the African-American sample.
One important aspect of any tagSNP algorithm is the fact that a set of tagSNPs is population specific. That is, tagSNPs determined for a European-descent sample should not be applied to an African-descent population. Also, tagSNPs should not be determined in a stratified or mixed population (such as the Polymorphism Discovery Resource Panel) and then applied to a defined population. There is evidence, however, that tagSNPs can be chosen in one sample and applied in another sample of similar race/ethnicity (51) . The difference across tagSNPs sets for different populations stems, in part, from differences in population history. As discussed above, it is well known that LD patterns differ across populations. The number of SNPs is different between two populations, with African-descent populations typically having the most variants compared with other populations. Also, a previous analysis of the SeattleSNPs PGA data set demonstrated that minor allele frequencies for the same sites can differ dramatically across different populations (9) . Thus, a common SNP in one sample may not necessarily be a common SNP in a second sample that differs by race/ethnicity.
VASCULAR CELL ADHESION MOLECULE 1 (VCAM1): AN AVERAGE GENE IN AN AVERAGE STUDY
This review has described two basic approaches for candidate gene association studies: direct and indirect. As a working example of these approaches, we apply the concepts described above to a SeattleSNPs PGA gene, vascular cell adhesion molecule 1 (VCAM1). VCAM1 is a member of the immuoglobulin gene superfamily induced by cytokines, and its upregulation has been noted at atherosclerotic lesions in mice (28) . VCAM1 is located at 1p32-p31 and is approximately 22. For a direct association study approach, we are interested in genotyping functional SNPs within VCAM1. VCAM1 contains six SNPs in the coding region. For the six cSNPs, two are synonymous and four are nonsynonymous. One of the nsSNPs, S318F (African-American MAF = 0.02; European-American MAF = 0.00), is predicted by PolyPhen to be possibly damaging/intolerant, making it a candidate for a direct association study. In examining the promoter region of VCAM1, we find a total of 10 SNPs within 2 kb of the start of transcription. We used Alibaba2.1 (see Electronic Databases) to identify SNPs occurring within predicted transcription factor binding sites (39) . Among these promoter SNPs, four occur within predicted transcription factor binding sites. Specifically, an T/C SNP -833 bp, T/G SNP -1599 bp, C/T SNP -2021 bp, and A/C SNP -2062 bp from the start of translation are predicted to fall within a Oct-1 or HNF-3 or C/EBP alpha, AP-1, Oct-1, and an ICSBP transcription factor binding site, respectively. Therefore, these SNPs should also be considered for an association study because it is possible that they have a functional effect by influencing the binding of transcription factors to the promoter region, resulting in allele-specific levels of VCAM1 gene expression.
For an indirect association study approach, we are interested in genotyping SNPs that are either the causative SNP or the SNP in LD with the causative SNP. Using LDSelect (10) with an r 2 threshold of 0.64 and a MAF threshold of ≥5%, we would choose 30 tagSNPs for the African-American sample and 305 11 tagSNPs in the European-American sample for genotyping in VCAM1. Alternatively, we could employ a haplotype tagging approach to choose tagSNPs. At a MAF ≥ 5%, the African-American sample has 44 inferred haplotypes and the European-American sample has 22 inferred haplotypes (PHASEv2.1; see Electronic Databases). Using the default settings for the D block definition in HaploBlockFinder (116), 29 tagSNPs in the African-American sample and 7 tagSNPs in the European-American sample were identified from inferred haplotypes in VCAM1 for genotyping.
CONCLUSIONS
We demonstrate here that much has been uncovered about the patterns of human gene variation through recent DNA variation discovery efforts. However, much remains to be learned about how these patterns can be applied to human genetic association studies to identify the loci involved in common human diseases. The data presented here suggest that specific approaches and methods may be appropriate for a proportion of the genes in the human genome, but may not be powerful or appropriate for other genes. This realization that one method does not fit all genetic association studies should stimulate creative thinking for alternative approaches to applying DNA variation in association studies so that the successes of the Human Genome Project will translate into successes of genomic medicine and public health for all populations.
Figure 2
The strength of pair-wise linkage disequilibrium (LD) varies dramatically across candidate genes and across different population samples. Pair-wise LD is measured using VG2, software that measures LD with r 2 or DЈ. Here, we measured LD using r 2 for all single nucleotide polymorphisms (SNPs) with a minor allele frequency of Ն5%. The strength of LD is depicted graphically for each pair-wise comparison (squares), such that white and blue represent low levels of LD and orange and red represent high levels of LD (see color key). The numbers along the triangle represent the SNPs, which are numbered according to a reference sequence. (25) and European Americans (15) .
